Pharmacokinetic Data Analysis and Reporting

The contract entails the analysis of plasma concentration-time data to determine pharmacokinetic parameters and generate detailed concentration-time curves, with all results delivered in a structured Excel report accompanied by a narrative summary that interprets the findings. The work is focused on quantitative evaluation of drug behavior in the body, requiring precise computational methods and regulatory-compliant reporting standards to ensure accuracy and reproducibility. The deliverables must be clearly formatted, scientifically sound, and tailored for use in regulatory submissions or internal R&D decision-making. This is a subcontract under the National Institutes of Health, operating through the Department of Health and Human Services, with the NAICS code 541690 indicating specialized scientific and technical consulting services. The opportunity was posted on August 7, 2026, with a response deadline of August 24, 2026, and no set-aside provisions are specified. While the place of performance and point of contact details are not provided, the work is expected to be performed remotely or under flexible arrangements, consistent with the nature of data analysis tasks. The contracting entity is seeking qualified contractors with demonstrated expertise in pharmacokinetic modeling and data reporting to support ongoing research initiatives.